Interferon Signaling Is Frequently Downregulated in Melanoma.

Alavi, Sara; Stewart, Ashleigh Jacqueline; Kefford, Richard F; Lim, Su Yin; Shklovskaya, Elena; Rizos, Helen

Alavi, Sara; Stewart, Ashleigh Jacqueline; Kefford, Richard F; Lim, Su Yin; Shklovskaya, Elena; Rizos, Helen.

Afiliação

Alavi S; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
Stewart AJ; Melanoma Institute Australia, Sydney, NSW, Australia.
Kefford RF; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
Lim SY; Melanoma Institute Australia, Sydney, NSW, Australia.
Shklovskaya E; Melanoma Institute Australia, Sydney, NSW, Australia.
Rizos H; Department of Clinical Medicine, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.

Front Immunol ; 9: 1414, 2018.

Article em En | MEDLINE | ID: mdl-29977240

Palavras-chave

PD-L1; PD-L2; antigen presentation; immunosuppression; interferon; melanoma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Immunol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google